Table 3.
Point Estimates and 95% CIs for aGMRs Associated With Each Model Covariate for Visit 3 (Post-Dose 2) HAI Titers to Influenza Antigens
| A/H1N1 | A/H3N2 | B/Victoria | ||||
|---|---|---|---|---|---|---|
| aGMR | 95% CI | aGMR | 95% CI | aGMR | 95% CI | |
| HD-TIV | 1.24 | [0.67, 2.36] | 2.25 | [1.20, 4.22] | 1.60 | [0.96, 2.67] |
| log2-baseline titer | 1.23 | [1.06, 1.43] | 1.33 | [1.16, 1.52] | 1.25 | [1.10, 1.41] |
| Age (y) | 1.00 | [0.98, 1.02] | 1.00 | [0.98, 1.02] | 0.99 | [0.98, 1.01] |
| Time post-HCT (mo) | 1.06 | [0.99, 1.14] | 1.06 | [1.00, 1.14] | 1.00 | [0.95, 1.06] |
| CD4+ count | 1.21 | [1.00, 1.47] | 1.14 | [0.94, 1.40] | 1.18 | [1.01, 1.39] |
| CD19+ count | 1.12 | [0.96, 1.29] | 1.24 | [1.07, 1.44] | 1.25 | [1.11, 1.40] |
| ALC (100/μL) | 0.96 | [0.91, 1.02] | 0.94 | [0.89, 1.00] | 0.94 | [0.90, 0.99] |
| GVHD history | 1.28 | [0.64, 2.54] | 0.83 | [0.41, 1.71] | 0.95 | [0.53, 1.67] |
Bolding indicates statistical significance at the 0.05 level (two-sided).
Abbreviations: AGMR, adjusted geometric mean ratio; ALC, absolute leukocyte count; CI, confidence interval; GVHD, graft versus host disease; HD-TIV, high-dose trivalent; SD-QIV, standard-dose quadrivalent.